Levocetirizine Dihydrochloride

Common brands: Xyzal, Xyzal Allergy 24hr, Allergy Relief, Basic Care Allergy Relief, Dg Health Allergy Relief

Top reporter: Chattem, Inc.

Nonsteroidal Anti-inflammatory Drug [EPC]Corticosteroid [EPC]Provitamin D2 Compound [EPC]Proton Pump Inhibitor [EPC]Benzodiazepine [EPC]
23,300
Total Reports
9,040
Serious Reports
970
Death Reports
30
Reported Reactions
Death Report Ratio: Moderate (4.16%)

Patient Demographics

Male
5,336
Female
13,015

Reported Adverse Reactions (30)

Side effects reported in FDA adverse event reports for Levocetirizine Dihydrochloride.

# Reaction Reports % of Total
1 DRUG INEFFECTIVE 3,035
11.5%
2 SOMNOLENCE 2,130
8.0%
3 FATIGUE 1,697
6.4%
4 HEADACHE 1,354
5.1%
5 PRURITUS 1,252
4.7%
6 NAUSEA 1,111
4.2%
7 DYSPNOEA 1,079
4.1%
8 DIARRHOEA 1,034
3.9%
9 DIZZINESS 902
3.4%
10 COUGH 803
3.0%
11 RASH 785
3.0%
12 ARTHRALGIA 768
2.9%
13 INSOMNIA 768
2.9%
14 OFF LABEL USE 735
2.8%
15 PYREXIA 723
2.7%
16 PAIN 717
2.7%
17 MALAISE 714
2.7%
18 VOMITING 648
2.4%
19 FALL 617
2.3%
20 FEELING ABNORMAL 597
2.3%
21 URTICARIA 557
2.1%
22 ASTHENIA 556
2.1%
23 PRODUCT DOSE OMISSION ISSUE 531
2.0%
24 SINUSITIS 531
2.0%
25 HYPERSENSITIVITY 508
1.9%
26 NO ADVERSE EVENT 477
1.8%
27 COVID-19 471
1.8%
28 PNEUMONIA 470
1.8%
29 CONDITION AGGRAVATED 453
1.7%
30 ASTHMA 449
1.7%

Important Disclaimer

FDA adverse event reports are submitted voluntarily and do not prove causation. A reported reaction does not mean the drug caused it. Drugs with more users naturally have more reports. Always consult your doctor or pharmacist before making medication decisions.